Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.
about
Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case reportSecondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.CML as Part of Dual Malignancies-A Retrospective Analysis: Possible Mechanisms and Review of Literature.An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.
P2860
Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Occurrence of secondary malign ...... single institution experience.
@ast
Occurrence of secondary malign ...... single institution experience.
@en
Occurrence of secondary malign ...... single institution experience.
@nl
type
label
Occurrence of secondary malign ...... single institution experience.
@ast
Occurrence of secondary malign ...... single institution experience.
@en
Occurrence of secondary malign ...... single institution experience.
@nl
prefLabel
Occurrence of secondary malign ...... single institution experience.
@ast
Occurrence of secondary malign ...... single institution experience.
@en
Occurrence of secondary malign ...... single institution experience.
@nl
P2093
P2860
P356
P1476
Occurrence of secondary malign ...... single institution experience.
@en
P2093
Andrzej Tukiendorf
Grażyna Bober
Lech Sedlak
Marek Seweryn
Ryszard Wichary
Sławomira Kyrcz-Krzemień
Tomasz Oleksy
P2860
P304
P356
10.4084/MJHID.2015.003
P577
2015-01-01T00:00:00Z